Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Working with the community

Community involvement plays an integral role in guiding our research - find out how.

Current Studies

The Western Australian Epithelial Research Program (WAERP) biobank is undertaking a number of research projects intended to improve the understanding and preclinical assessment of therapeutics for respiratory conditions.

START Phage WA

START Phage WA was formed to pave the way towards treating AMR infections with phage therapy in Western Australia.

Western Australian Epithelial Research Program

The Western Australian Epithelial Research Program (WAERP) is a community cohort biobank that collects and stores airway cells from the upper (nose) and lower (trachea) airways of Western Australian children and adults (1-50 years of age) undergoing non respiratory elective surgery.

Annual Giving

Your generosity creates a significant impact on our research and on the lives of children everywhere

Meet the team

Meet the team behind the Beacon app.

News & Events

DiabHQ App Rollout

The new DiabHQ Patient Portal App for WA children and families living with type 1 diabetes is now available.

News & Events

World Autism Day: Championing inclusion through research, resources, and support

Today, on World Autism Day, we embrace the theme Celebrating Differences, recognising the unique strengths, perspectives, and contributions of autistic individuals.

News & Events

Professor Britta Regli-von Ungern-Sternberg awarded 2025 Jian Zou Medal

Congratulations to Professor Britta Regli-von Ungern-Sternberg, who was today recognised as one of Australia’s rising leaders in health and medical sciences upon being awarded the Australian Academy of Health and Medical Sciences 2025 Jian Zou Medal.

News & Events

Study which deliberately infected participants leads to penicillin breakthrough

A unique study purposely giving participants Streptococcus pyogenes (Strep A) to learn how much penicillin it takes to prevent infection has found the amount needed is much lower than previously thought – a discovery that will transform thinking on treatment for people living with rheumatic heart disease (RHD).